Literature DB >> 17191251

Microparticles and nanoparticles for drug delivery.

Daniel S Kohane1.   

Abstract

Particulate drug delivery systems have become important in experimental pharmaceutics and clinical medicine. The distinction is often made between micro- and nanoparticles, being particles with dimensions best described in micrometers and nanometers respectively. That size difference entails real differences at many levels, from formulation to in vivo usage. Here I will discuss those differences and provide examples of applications, for local and systemic drug delivery. I will outline a number of challenges of interest in particulate drug delivery. (c) 2006 Wiley Periodicals, Inc.

Mesh:

Year:  2007        PMID: 17191251     DOI: 10.1002/bit.21301

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  98 in total

1.  Size mapping of electric field-assisted production of polycaprolactone particles.

Authors:  M Enayati; Z Ahmad; E Stride; M Edirisinghe
Journal:  J R Soc Interface       Date:  2010-06-02       Impact factor: 4.118

2.  Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes.

Authors:  Candace C Fleischer; Christine K Payne
Journal:  J Phys Chem B       Date:  2012-07-20       Impact factor: 2.991

3.  Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.

Authors:  Sean M Geary; Qiaohong Hu; Vijaya B Joshi; Ned B Bowden; Aliasger K Salem
Journal:  J Control Release       Date:  2015-09-08       Impact factor: 9.776

Review 4.  Micro and nanoparticle drug delivery systems for preventing allotransplant rejection.

Authors:  James D Fisher; Abhinav P Acharya; Steven R Little
Journal:  Clin Immunol       Date:  2015-05-01       Impact factor: 3.969

5.  Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses.

Authors:  Naihan Chen; Monica M Johnson; Michael A Collier; Matthew D Gallovic; Eric M Bachelder; Kristy M Ainslie
Journal:  J Control Release       Date:  2018-02-02       Impact factor: 9.776

6.  Microparticulate systems for targeted drug delivery to phagocytes.

Authors:  Siddharth Jhunjhunwala; Steven R Little
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

7.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles.

Authors:  Timothy J Merkel; Stephen W Jones; Kevin P Herlihy; Farrell R Kersey; Adam R Shields; Mary Napier; J Christopher Luft; Huali Wu; William C Zamboni; Andrew Z Wang; James E Bear; Joseph M DeSimone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

8.  Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres.

Authors:  Jamal S Lewis; Chris Roche; Ying Zhang; Todd M Brusko; Clive H Wasserfall; Mark Atkinson; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  J Mater Chem B       Date:  2014-05-07       Impact factor: 6.331

9.  Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists.

Authors:  Michael A Collier; Robert D Junkins; Matthew D Gallovic; Brandon M Johnson; Monica M Johnson; Andrew N Macintyre; Gregory D Sempowski; Eric M Bachelder; Jenny P-Y Ting; Kristy M Ainslie
Journal:  Mol Pharm       Date:  2018-10-15       Impact factor: 4.939

Review 10.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.